Mirum Pharmaceuticals, Inc. Income Tax Expense (Benefit) in USD from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Mirum Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q3 2025.
  • Mirum Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was -$262K, a 176% decline year-over-year.
  • Mirum Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $593K, a 67.6% decline year-over-year.
  • Mirum Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2024 was $1.03M, a 3.94% increase from 2023.
  • Mirum Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $991K.
  • Mirum Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$6.41M, a 17414% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

Mirum Pharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $593K -$262K -$609K -176% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $1.2M $402K -$233K -36.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $1.44M $1.03M +$405K +64.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $1.03M -$576K -$801K -356% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-26
Q3 2024 $1.83M $347K +$98K +39.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 $1.73M $635K +$319K +101% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $1.41M $624K +$423K +210% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 $991K $225K +$85K +60.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-26
Q3 2023 $906K $249K +$236K +1815% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $670K $316K +$6.89M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$6.22M $201K +$190K +1727% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$6.41M $140K +$128K +1067% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-26
Q3 2022 -$6.53M $13K +$4K +44.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$6.54M -$6.57M -$6.58M -59827% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $43K $11K +$6K +120% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $37K $12K +$10K +500% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 $27K $9K +$12K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $15K $11K +$8K +267% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $7K $5K +$1K +25% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $6K $2K -$19K -90.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 $25K -$3K -$3K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $28K $3K +$3K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $25K $4K +$4K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $21K $21K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-28

Mirum Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.03M +$39K +3.94% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 $991K +$7.4M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 -$6.41M -$6.44M -17414% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 $37K +$31K +517% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $6K -$15K -71.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $21K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.